• The Synergy Between Call Centers And Population Health
    Healthcare is evolving from a fee-for-service and volume-driven model to one that is value based. The Centers for Medicare & Medicaid Services has stepped up its timeline for shifting Medicare to a value-based system so that by the end of 2016, at least 30% of fee-for-service Medicare payments will be tied to value through accountable care organizations or bundled payment arrangements. By the end of 2018, that number will increase to 50%.
  • Pharma And Digital Innovation: A Missed Opportunity?
    The "Wall Street Journal" suggests that entrepreneurs and innovators are not paying enough attention to the growing and pressing needs of pharmaceutical companies in the digital health arena. But is this really the case?
  • Pharma's Guide To Being 'Smart' About The Apple Watch
    While the Apple Watch still rolls out to the initial pre-order customers, the pharma industry is making changes. Android has rolled out major updates to Android Wear to compete with the Apple Watch and app developers are lining up to add to the over 3,500 existing Apple Watch enabled apps. But what about you? What is your plan to understand how this new screen will impact your efforts?
  • Pharma Moves Into Digital Health
    The announcement that Novartis and Qualcomm Ventures have formed a joint venture to invest $100 million in digital health is significant and suggests that big pharma is transitioning from talk to action in the strategy to "move beyond the pill."
  • Why The Future Of Healthcare Will Be Smarter Than The Past
    Last night, I was at a graduate student class presentation at NYU on the future of media. The focus was on four scenarios around automation, surveillance, semantic web, and the rise of women as global catalysts. Thought-provoking as each scenario was, it got me thinking about the future of healthcare in exactly these terms - the role of automation from treatment decision support to robot-assisted surgery, the activation of remote tracking and monitoring of patient compliance and biometrics, peer-enabled learning and disease management for both physicians and patients, and the role of gender, race, and genetics in screening and treating ...
  • The Dawn Of The Apple Watch Health Apps
    Despite that most of the people who have ordered an Apple Watch haven't received it yet, history tells us that when Apple gets into a new area of activity, big things happen. No wonder tech fans and stock pickers have been so excited about the Apple Watch. What is the watch going to revolutionize?
  • Call Centers - Filling The Gaps In The Patient Care Continuum
    A report in Healthcare IT News, "Strategies to Maximize Patient Engagement and Retention," observed that the healthcare industry is evolving to a model where patients are approaching their healthcare as consumers. As a result, patients' expectations of an "exceptional care experience" are requiring that providers start engaging patients not only during office visits, but throughout the care continuum. To achieve this end, the single most important component is communication.
  • Can Digital Innovation Save Humanity?
    These days, marketers are doing a lot more than developing advertisements and public relations campaigns. They are actively developing, investing in and helping to shape all kinds of digital innovations, from mobile applications to wearables.
  • Finding Humanity At The Intersection Of Health And Technology
    Over the last few months, there's been increasing excitement around the innovations in health tech. You know health tech is at critical mass when it hits center stage at SXSW, and the Apple ResearchKit introduction promises to bring together personal healthcare data from a huge proportion of the population. With all the hubbub around the latest innovations, it's important to identify the human stories at the center of the technology, which supports why the technology isn't only inevitable, but necessary.
  • Keeping Things In Perspective: Stop Beating Up The Pharma Sales Rep
    Pharma is in the spotlight again, but not for the right reasons. In a recent post on the Denialism blog, Mark Hoofnagle discusses John Oliver's "Last Week Tonight" report about the influence of sales reps in the pharma industry. So what's going on here?
« Previous Entries Next Entries »